Oncology Research Program Area
The AKC Canine Health Foundation has strongly supported cancer research since its inception in 1995. Cancer medicine has evolved significantly during this time into a more molecular-based discipline with improved diagnosis and tumor imaging, and the discovery of novel therapeutics aimed at cancer-specific cellular signal transduction pathways and personalized medicine. The Foundation remains committed to the promotion of innovative research that will aid in the discovery of advanced diagnostic technology and therapeutic target identification, and a comparative oncology approach to advancements for dogs and their people.
As with all other research program areas, collaborative, multi-disciplinary teams of investigators who can approach discovery research from a multi-‘omics’ perspective will be considered more competitive than a genomic approach working in isolation. Beyond the molecular and genetic basis of disease, the Oncology Research Program Area will continue to support the identification and evaluation of potential therapeutics to treat canine cancer, and wants to further understanding of cancer prevalence by breed and geographic region with consideration for potential environmental influences on disease. An epidemiological approach to oncology research and the understanding of canine cancer will be an important component within this program area.
Special topics of interest within the Oncology Research Program Area include, but are not limited to:
- Mammary Tumors
- Mast Cell Tumors
- Soft-tissue Sarcoma
- Squamous Cell Carcinoma
- Transitional Cell Carcinoma
- Brain Tumors
- Thyroid Carcinoma
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.